0006-5003 : Prevymis 20 mg/ml Intravenous Injection, Solution


NDC: 0006-5003
Labeler: Merck Sharp & Dohme Corp.
Product Type: Human Prescription Drug
Drug Name:  Prevymis
Dosage Form: Intravenous Injection, Solution
Application #: NDA209940
Rev. Date: 


NDC Package Codes:

  • 0006-5003-01: 1 VIAL, SINGLE‑DOSE IN 1 CARTON (0006‑5003‑01) > 12 ML IN 1 VIAL, SINGLE‑DOSE (0006‑5003‑02)

Active Ingredients:

  • Letermovir

Dosage Strength:

  • 20 mg/mL

Pharmaceutical Classes:

  • Cytomegalovirus DNA Terminase Complex Inhibitor [EPC]
  • DNA Terminase Complex Inhibitors [MoA]
  • Cytochrome P450 3A Inhibitors [MoA]
  • Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]
  • Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]
  • Cytochrome P450 2C8 Inhibitors [MoA]
  • Cytochrome P450 2C9 Inducers [MoA]
  • Cytochrome P450 2C19 Inducers [MoA]

Related Products:

Based on records with the same trade name.
  • 0006-3075 Prevymis 240 mg Oral Tablet, Film Coated by Merck Sharp & Dohme Corp.
  • 0006-3076 Prevymis 480 mg Oral Tablet, Film Coated by Merck Sharp & Dohme Corp.
  • 0006-5004 Prevymis 20 mg/ml Intravenous Injection, Solution by Merck Sharp & Dohme Corp.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 0006-5003 QR Code

< Prev: 0006-4999Next: 0006-5004 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.